These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 10701363

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. In vivo measurements of intratumoral metabolism, modulation, and pharmacokinetics of 5-fluorouracil, using 19F nuclear magnetic resonance spectroscopy.
    el-Tahtawy A, Wolf W.
    Cancer Res; 1991 Nov 01; 51(21):5806-12. PubMed ID: 1933851
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Enhancement of fluorouracil uptake in human colorectal and gastric cancers by interferon or by high-dose methotrexate: An in vivo human study using noninvasive (19)F-magnetic resonance spectroscopy.
    Presant CA, Wolf W, Waluch V, Wiseman CL, Weitz I, Shani J.
    J Clin Oncol; 2000 Jan 01; 18(2):255-61. PubMed ID: 10637237
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Locoregional administration of 5-fluoro-2'-deoxyuridine (FdUrd) in Novikoff hepatoma in the rat: effects of dose and infusion time on tumor growth and on FdUrd metabolite levels in tumor tissue as determined by 19F-NMR spectroscopy.
    Naser-Hijazi B, Berger MR, Schmähl D, Schlag P, Hull WE.
    J Cancer Res Clin Oncol; 1991 Jan 01; 117(4):295-304. PubMed ID: 1829730
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Direct detection of intratumoral 5-fluorouracil trapping using metabolic 19F MR imaging.
    Brix G, Bellemann ME, Gerlach L, Haberkorn U.
    Magn Reson Imaging; 1999 Jan 01; 17(1):151-5. PubMed ID: 9888408
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Trimetrexate: experience with solid tumors.
    Haller DG.
    Semin Oncol; 1997 Oct 01; 24(5 Suppl 18):S18-71-S18-76. PubMed ID: 9420024
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Assessment of the biodistribution and metabolism of 5-fluorouracil as monitored by 18F PET and 19F MRI: a comparative animal study.
    Brix G, Bellemann ME, Haberkorn U, Gerlach L, Lorenz WJ.
    Nucl Med Biol; 1996 Oct 01; 23(7):897-906. PubMed ID: 8971857
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Biochemical modulation of the catabolism and tissue uptake of the anticancer drug 5-fluorouracil by 5-bromovinyluracil: assessment with metabolic (19)F MR imaging.
    Brix G, Bellemann ME, Haberkorn U.
    Magn Reson Med; 1999 Nov 01; 42(5):936-43. PubMed ID: 10542353
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.